Humoral immune response to SARS-CoV-2 mRNA vaccines is associated with choice of vaccine and systemic adverse reactions

PURPOSE: Although the fast development of safe and effective messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 has been a success, waning humoral immunity has led to the recommendation of booster immunization. However, knowledge of the humoral immune response to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Klingel, Hanna, Krüttgen, Alexander, Imöhl, Matthias, Kleines, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Vaccine Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950231/
https://www.ncbi.nlm.nih.gov/pubmed/36844685
http://dx.doi.org/10.7774/cevr.2023.12.1.60

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950231/
https://www.ncbi.nlm.nih.gov/pubmed/36844685
http://dx.doi.org/10.7774/cevr.2023.12.1.60

Ejemplares similares